Post-IPO Debt - BiolineRx
Investment Firm
Overview
BioLineRx is a late clinical-stage biopharmaceutical development company that focuses on oncology.
Announced Date
Apr 10, 2024
Funding Type
Post Ipo Debt
Highlights
Location
Asia
Social
Investor Lead
N/A
Participant Investors
2
| Investor Name |
|---|
 Kreos Capital |
Round Details and Background
BiolineRx raised $20000000 on 2024-04-10 in Post-IPO Debt
BioLineRx is a late clinical-stage biopharmaceutical development company that focuses on oncology.
Company Funding History
16
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| May 04, 2004 |  Venture Round - BiolineRx | 2 | - | 4.0M |
| Mar 05, 2015 | Post-IPO Equity - BiolineRx | - | 25.0M | |
| Dec 17, 2014 | Post-IPO Equity - BiolineRx | 1 | - | 10.0M |
| Mar 07, 2014 | Post-IPO Equity - BiolineRx | - | 24.1M |
Recent Activity
There is no recent news or activity for this profile.